Skip to content

Comparison of SMS and IVR Surveys in Tanzania

Comparison of Short Message Service (SMS) and Interactive Voice Response (IVR) Mobile Phone Surveys for Non-communicable Disease Risk Factor Surveillance in Tanzania

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04506918
Enrollment
6483
Registered
2020-08-10
Start date
2020-10-23
Completion date
2021-04-30
Last updated
2022-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Noncommunicable Diseases, Surveys and Questionnaires

Keywords

mobile phone surveys, interactive voice response, short message service

Brief summary

This study focuses on mechanisms to adapt the performance of interactive voice response (IVR) and short message service (SMS) surveys conducted in low-and middle-income (LMIC) setting (Tanzania) and evaluates how the two survey modalities (IVR and SMS) affect survey metrics, including response, completion and attrition rates.

Detailed description

Using random digit dialing (RDD) sampling technique, participants will be randomized to one of two arms : 1) IVR or 2) SMS. Participants in the first study arm will receive an IVR survey. Participants in the second study arm will receive a SMS survey. The IVR and SMS questionnaires contain a set of demographic questions and one non-communicable disease (NCD) module (alcohol, or tobacco, or diet, or physical activity, or blood pressure and diabetes). We will examine contact, response, refusal and cooperation rates and demographic representativeness by each study arm.

Interventions

Participants will receive an IVR survey

Participants will receive a SMS survey

Sponsors

Ifakara Health Institute
CollaboratorOTHER
Johns Hopkins Bloomberg School of Public Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Participants will be randomized to one of two arms : 1) IVR or 2) SMS. Participants in the first study arm will receive an IVR survey. Participants in the second study arm will receive a SMS survey.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Access to a mobile phone * Greater or equal to 18 years of age * Conversant in the Swahili language

Exclusion criteria

* Less than 18 years of age

Design outcomes

Primary

MeasureTime frameDescription
Cooperation Rate #1Through study completion, an average of one monthAs defined by American Association for Public Opinion Research, cooperation rate is defined as I/(I+P+R) where I is the number of participants with complete interviews, P is the number of participants with partial interviews, and R is the number of participants with refusals and breakoffs.
Response Rate #4Through study completion, an average of one monthAs defined by American Association for Public Opinion Research, response rate is defined as (I+P)/(I+P+R+eU) where I is the number of participants with complete interviews, P is the number of participants with partial interviews, R is the number of participants with refusals and breakoffs, and eU is the estimated eligible proportion of unknowns

Secondary

MeasureTime frameDescription
Refusal Rate #2Through study completion, an average of one monthAs defined by American Association for Public Opinion Research, refusal rate is defined as (R)/(I+P+R+eU) where R is the number of participants with refusals and breakoffs, I is the number of participants with complete interviews, P is the number of participants with partial interviews, and eU is the estimated eligible proportion of unknowns
Contact Rate #2Through study completion, an average of one monthAs defined by American Association for Public Opinion Research, contact rate is defined as (I+P+R)/(I+P+R+eU) where I is the number of participants with complete interviews, P is the number of participants with partial interviews, R is the number of participants with refusals and breakoffs, and eU is the estimated eligible proportion of unknowns

Countries

Tanzania

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026